Skip to main content
Erschienen in: AIDS and Behavior 1/2013

01.01.2013 | Original Paper

Early Uptake of HIV Clinical Care After Testing HIV-Positive During Home-Based Testing and Counseling in Western Kenya

verfasst von: Amy Medley, Marta Ackers, Manase Amolloh, Patrick Owuor, Helen Muttai, Beryl Audi, Manquins Sewe, Kayla Laserson

Erschienen in: AIDS and Behavior | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Home-based HIV testing and counseling (HBTC) has the potential to increase access to HIV testing. However, the extent to which HBTC programs successfully link HIV-positive individuals into clinical care remains unclear. To determine factors associated with early enrollment in HIV clinical care, adult residents (aged ≥13 years) in the Health and Demographic Surveillance System in Kisumu, Kenya were offered HBTC. All HIV-positive residents were referred to nearby HIV clinical care centers. Two to four months after HBTC, peer educators conducted home visits to consenting HIV-positive residents. Overall, 9,895 (82 %) of 12,035 residents accepted HBTC; 1,087 (11 %) were HIV-positive; and 737 (68 %) received home visits. Of those receiving home visits, 42 % reported HIV care attendance. Factors associated with care attendance included: having disclosed, living with someone attending HIV care, and wanting to seek care after diagnosis. Residents who reported their current health as excellent or who doubted their HBTC result were less likely to report care attendance. While findings indicate that HBTC was well-received in this setting, less than half of HIV-positive individuals reported current care attendance. Identification of effective strategies to increase early enrollment and retention in HIV clinical care is critical and will require coordination between testing and treatment program staff and systems.
Literatur
2.
Zurück zum Zitat Crum NF, Riffenburgh RH, Wegner S, Agan B, Tasker S, Spooner K, et al. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr. 2006;41:194–200.PubMedCrossRef Crum NF, Riffenburgh RH, Wegner S, Agan B, Tasker S, Spooner K, et al. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr. 2006;41:194–200.PubMedCrossRef
3.
Zurück zum Zitat Lima V, Harrigan R, Bangsberg D, Hogg R, Gross R, Yip B, et al. The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. J Acquir Immune Defic Syndr. 2009;50:529–36.PubMedCrossRef Lima V, Harrigan R, Bangsberg D, Hogg R, Gross R, Yip B, et al. The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. J Acquir Immune Defic Syndr. 2009;50:529–36.PubMedCrossRef
4.
Zurück zum Zitat Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, HPTN 052 Study Team, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493–505.PubMedCrossRef Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, HPTN 052 Study Team, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493–505.PubMedCrossRef
5.
Zurück zum Zitat Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009;23:1397–404.PubMedCrossRef Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009;23:1397–404.PubMedCrossRef
6.
Zurück zum Zitat Donnell D, Baeten JM, Kiaire J, Thomas KK, Stevens W, Cohen CR, Partners in Prevention HSV/HIV Transmission Study Team, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010;375:2092–8.PubMedCrossRef Donnell D, Baeten JM, Kiaire J, Thomas KK, Stevens W, Cohen CR, Partners in Prevention HSV/HIV Transmission Study Team, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010;375:2092–8.PubMedCrossRef
7.
Zurück zum Zitat Kenya National AIDS Control Council. Kenya National AIDS Strategic Plan, 2009/2010–2012/13: delivering on universal access to services. Nairobi: National AIDS Control Council; 2009. Kenya National AIDS Control Council. Kenya National AIDS Strategic Plan, 2009/2010–2012/13: delivering on universal access to services. Nairobi: National AIDS Control Council; 2009.
8.
Zurück zum Zitat Adazu K, Lindblade KA, Rosen DH, Odhiambo F, Ofware P, Kwach J, et al. Health and demographic surveillance in rural western Kenya: a platform for evaluating interventions to reduce morbidity and mortality from infectious diseases. Am J Trop Med Hyg. 2005;73:1151–8.PubMed Adazu K, Lindblade KA, Rosen DH, Odhiambo F, Ofware P, Kwach J, et al. Health and demographic surveillance in rural western Kenya: a platform for evaluating interventions to reduce morbidity and mortality from infectious diseases. Am J Trop Med Hyg. 2005;73:1151–8.PubMed
9.
Zurück zum Zitat Ombok M, Adazu K, Odihambo F, Bayoh N, Kiriinya R, Slutsker L, et al. Geospatial distribution and determinants of child mortality in rural western Kenya 2002–2005. Trop Med Int Health. 2010;15:423–33.PubMedCrossRef Ombok M, Adazu K, Odihambo F, Bayoh N, Kiriinya R, Slutsker L, et al. Geospatial distribution and determinants of child mortality in rural western Kenya 2002–2005. Trop Med Int Health. 2010;15:423–33.PubMedCrossRef
10.
Zurück zum Zitat Zeger S, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121–30.PubMedCrossRef Zeger S, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121–30.PubMedCrossRef
11.
Zurück zum Zitat Hatcher A, Turan J, Leslie H, Kanya L, Kwena Z, Johnson M, et al. Predictors of linkage to care following community-based HIV counseling and testing in rural Kenya. AIDS Behav. 2012;16:1295–307.PubMedCrossRef Hatcher A, Turan J, Leslie H, Kanya L, Kwena Z, Johnson M, et al. Predictors of linkage to care following community-based HIV counseling and testing in rural Kenya. AIDS Behav. 2012;16:1295–307.PubMedCrossRef
12.
Zurück zum Zitat Assefa Y, Van D, Mariam DH, Kloos H. Toward universal access to HIV counseling and testing and antiretroviral treatment in Ethiopia: looking beyond HIV testing and ART initiation. AIDS Patient Care STDS. 2010;24:521–5.PubMedCrossRef Assefa Y, Van D, Mariam DH, Kloos H. Toward universal access to HIV counseling and testing and antiretroviral treatment in Ethiopia: looking beyond HIV testing and ART initiation. AIDS Patient Care STDS. 2010;24:521–5.PubMedCrossRef
13.
Zurück zum Zitat Govindasamy D, van Schaik N, Kranzer K, Wood R, Matthews C, Bekker LG. Linkage to HIV care from a mobile testing unit in South Africa by different CD4 count strata. J Acquir Immune Defic Syndr. 2011;58(3):344–52.PubMedCrossRef Govindasamy D, van Schaik N, Kranzer K, Wood R, Matthews C, Bekker LG. Linkage to HIV care from a mobile testing unit in South Africa by different CD4 count strata. J Acquir Immune Defic Syndr. 2011;58(3):344–52.PubMedCrossRef
14.
Zurück zum Zitat Govindasamy D, Ford N, Kranzer K. Risk factors, barriers, and facilitators for linkage to ART care in sub-Saharan Africa: a systematic review. AIDS. 2012; (epub). Govindasamy D, Ford N, Kranzer K. Risk factors, barriers, and facilitators for linkage to ART care in sub-Saharan Africa: a systematic review. AIDS. 2012; (epub).
15.
Zurück zum Zitat Posse M, Baltussen R. Barriers to access to antiretroviral treatment in Mozambique, as perceived by patients and health workers in urban and rural settings. AIDS Patient Care STDS. 2009;23:867–75.PubMedCrossRef Posse M, Baltussen R. Barriers to access to antiretroviral treatment in Mozambique, as perceived by patients and health workers in urban and rural settings. AIDS Patient Care STDS. 2009;23:867–75.PubMedCrossRef
16.
Zurück zum Zitat Zachariah R, Harries AD, Manzi M, Gomanj P, Teck R, Philips M, et al. Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport. PLoS One. 2006;1:e121.PubMedCrossRef Zachariah R, Harries AD, Manzi M, Gomanj P, Teck R, Philips M, et al. Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport. PLoS One. 2006;1:e121.PubMedCrossRef
17.
Zurück zum Zitat Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19:658–65.PubMedCrossRef Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19:658–65.PubMedCrossRef
18.
Zurück zum Zitat Miller CM, Kelthapile M, Rybasack-Smith H, Rosen S. Why are antiretroviral treatment patients lost to follow-up? A qualitative study from South Africa. Trop Med Int Health. 2010;15(suppl 1):48–54.PubMedCrossRef Miller CM, Kelthapile M, Rybasack-Smith H, Rosen S. Why are antiretroviral treatment patients lost to follow-up? A qualitative study from South Africa. Trop Med Int Health. 2010;15(suppl 1):48–54.PubMedCrossRef
19.
Zurück zum Zitat Harries AD, Zachariah R, Lawn SD, Rosen S. Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa. Trop Med Int Health. 2010;15(suppl 1):70–5.PubMedCrossRef Harries AD, Zachariah R, Lawn SD, Rosen S. Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa. Trop Med Int Health. 2010;15(suppl 1):70–5.PubMedCrossRef
20.
Zurück zum Zitat Geng EH, Nash D, Kambugu A, Zhang Y, Braitstein P, Christopoulos KA, et al. Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep. 2010;7:234–44.PubMedCrossRef Geng EH, Nash D, Kambugu A, Zhang Y, Braitstein P, Christopoulos KA, et al. Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep. 2010;7:234–44.PubMedCrossRef
21.
Zurück zum Zitat Abaynew Y, Deribew A, Deribe K. Factors associated with late presentation to HIV/AIDS care in South Wollo Zone Ethiopia: a case–control study. AIDS Res Ther. 2011;8:8.PubMedCrossRef Abaynew Y, Deribew A, Deribe K. Factors associated with late presentation to HIV/AIDS care in South Wollo Zone Ethiopia: a case–control study. AIDS Res Ther. 2011;8:8.PubMedCrossRef
22.
Zurück zum Zitat Lawn S, Harries A, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;22:1897–908.PubMedCrossRef Lawn S, Harries A, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;22:1897–908.PubMedCrossRef
23.
Zurück zum Zitat Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, Emenyonu NI, et al. Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in sub-Saharan Africa. J Acquir Immune Defic Syndr. 2009;52:280–9.PubMedCrossRef Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, Emenyonu NI, et al. Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in sub-Saharan Africa. J Acquir Immune Defic Syndr. 2009;52:280–9.PubMedCrossRef
24.
Zurück zum Zitat Battegay M, Fluckiger U, Hirschel B, Furrer H. Late presentation of HIV-infected individuals. Antivir Ther. 2007;12:841–51.PubMed Battegay M, Fluckiger U, Hirschel B, Furrer H. Late presentation of HIV-infected individuals. Antivir Ther. 2007;12:841–51.PubMed
25.
Zurück zum Zitat Lawn SD, Harries AD, Wood R. Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings. Curr Opin HIV/AIDS. 2010;5:18–26.CrossRef Lawn SD, Harries AD, Wood R. Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings. Curr Opin HIV/AIDS. 2010;5:18–26.CrossRef
26.
Zurück zum Zitat Lahuerta M, Lima J, Elul B, Okamura M, Alvim MF, Nuwagaba-Birbonwoha H, et al. Patients enrolled in HIV care in Mozambique: baseline characteristics and follow-up outcomes. J Acquir Immune Defic Syndr. 2011;58:e75–86.PubMedCrossRef Lahuerta M, Lima J, Elul B, Okamura M, Alvim MF, Nuwagaba-Birbonwoha H, et al. Patients enrolled in HIV care in Mozambique: baseline characteristics and follow-up outcomes. J Acquir Immune Defic Syndr. 2011;58:e75–86.PubMedCrossRef
27.
Zurück zum Zitat Ware NC, Idoko J, Kaaya S, Biraro IA, Wyatt MA, Agabji O, et al. Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS Med. 2009;6:e11.PubMedCrossRef Ware NC, Idoko J, Kaaya S, Biraro IA, Wyatt MA, Agabji O, et al. Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS Med. 2009;6:e11.PubMedCrossRef
28.
Zurück zum Zitat Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes. Bull World Health Organ. 2004;82:299–307.PubMed Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes. Bull World Health Organ. 2004;82:299–307.PubMed
29.
Zurück zum Zitat Rosen S, Fox M. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 2011;8:e1001056.PubMedCrossRef Rosen S, Fox M. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 2011;8:e1001056.PubMedCrossRef
30.
Zurück zum Zitat Wachira J, Kimaiyo S, Ndege S, Mamlin J, Braitstein P. What is the impact of home-based HIV counseling and testing on the clinical status of newly enrolled adults in a large HIV care program in Western Kenya? Clin Infect Dis. 2012;54(2):275–81.PubMedCrossRef Wachira J, Kimaiyo S, Ndege S, Mamlin J, Braitstein P. What is the impact of home-based HIV counseling and testing on the clinical status of newly enrolled adults in a large HIV care program in Western Kenya? Clin Infect Dis. 2012;54(2):275–81.PubMedCrossRef
31.
Zurück zum Zitat Nakanjako D, Colebunders R, Coutinho AG, Kamya MR. Strategies to optimize HIV treatment outcomes in resource-limited settings. AIDS Rev. 2009;11:179–89.PubMed Nakanjako D, Colebunders R, Coutinho AG, Kamya MR. Strategies to optimize HIV treatment outcomes in resource-limited settings. AIDS Rev. 2009;11:179–89.PubMed
32.
Zurück zum Zitat Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52:793–800.PubMedCrossRef Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52:793–800.PubMedCrossRef
Metadaten
Titel
Early Uptake of HIV Clinical Care After Testing HIV-Positive During Home-Based Testing and Counseling in Western Kenya
verfasst von
Amy Medley
Marta Ackers
Manase Amolloh
Patrick Owuor
Helen Muttai
Beryl Audi
Manquins Sewe
Kayla Laserson
Publikationsdatum
01.01.2013
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 1/2013
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-012-0344-5

Weitere Artikel der Ausgabe 1/2013

AIDS and Behavior 1/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.